Multiple myeloma – bortezomib Continuing PBS authority application Supporting information form (PB102)

You must lodge this form for a patient continuing Pharmaceutical Benefits Scheme (PBS) subsidised treatment with bortezomib for multiple myeloma.

 

Page last updated: 13 July 2016

This information was printed Tuesday 27 September 2016 from humanservices.gov.au/health-professionals/forms/pb102 It may not include all of the relevant information on this topic. Please consider any relevant site notices at humanservices.gov.au/siteinformation when using this material.